TRxADE HEALTH, Inc. (MEDS)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 8.09M |
| Enterprise Value | 15.04M |
| Trailing P/E | N/A |
| Forward P/E | 21.83 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.66 |
| Price/Book (mrq) | 14.91 |
| Enterprise Value/Revenue | 1.82 |
| Enterprise Value/EBITDA | -5.94 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.04 |
| 52-Week Change 3 | 27.78% |
| S&P500 52-Week Change 3 | 28.04% |
| 52 Week High 3 | 44.56 |
| 52 Week Low 3 | 3.69 |
| 50-Day Moving Average 3 | 10.96 |
| 200-Day Moving Average 3 | 7.79 |
Share Statistics
| Avg Vol (3 month) 3 | 226.77k |
| Avg Vol (10 day) 3 | 8.85k |
| Shares Outstanding 5 | 1.41M |
| Implied Shares Outstanding 6 | 1.43M |
| Float 8 | 810.13k |
| % Held by Insiders 1 | 24.06% |
| % Held by Institutions 1 | 10.25% |
| Shares Short (Apr 30, 2024) 4 | 12.17k |
| Short Ratio (Apr 30, 2024) 4 | 0.45 |
| Short % of Float (Apr 30, 2024) 4 | 1.12% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 0.87% |
| Shares Short (prior month Mar 28, 2024) 4 | 34.03k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Mar 22, 2024 |
| Ex-Dividend Date 4 | Mar 25, 2024 |
| Last Split Factor 2 | 1:15 |
| Last Split Date 3 | Jun 22, 2023 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -215.71% |
| Operating Margin (ttm) | -263.25% |
Management Effectiveness
| Return on Assets (ttm) | -55.90% |
| Return on Equity (ttm) | -3,099.92% |
Income Statement
| Revenue (ttm) | 8.27M |
| Revenue Per Share (ttm) | 10.83 |
| Quarterly Revenue Growth (yoy) | 4.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -7.24M |
| Net Income Avi to Common (ttm) | -13.72M |
| Diluted EPS (ttm) | -17.96 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 151.91k |
| Total Cash Per Share (mrq) | 0.11 |
| Total Debt (mrq) | 7.1M |
| Total Debt/Equity (mrq) | 1,309.83% |
| Current Ratio (mrq) | 0.24 |
| Book Value Per Share (mrq) | 0.60 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2.07M |
| Levered Free Cash Flow (ttm) | -2.19M |
© 2024 Yahoo. All rights reserved.